Treatment for Hepatitis C Virus and Cannabis Use in Illicit Drug User Patients: Implications and Questions
B. Fischer et al, "Treatment for hepatitis C virus and cannabis use in illicit drug user patients: Implications and questions," European Journal of Gastroenterology and Hepatology 18, issue 10 (October 2006): 1039-1042.
This commentary, published alongside Diana Sylvestre's landmark study of marijuana use by hepatitis C (HCV) patients (see "Cannabis use improves retention and virological outcomes in patients treated for hepatitis C," above), was written by a separate team of Canadian researchers. They describe the evidence that marijuana relieves debilitating side effects of treatment for HCV, cancer, and AIDS and call for patients to be legally permitted to use it.
Free full text available at http://www.eurojgh.com/.
